Skip to main content

Cancer Immunotherapy for Internists- 1.25 CME Credits

Start Date: Jan 3, 2019
Duration: 1.25 hours
Price: $65

Course Description

This course focuses on an update in cancer immunotherapy. Beginning with the relationship between therapy interventions and human cancer, this course then covers the immunity cycles as well as the various treatments, drugs, and algorithms related to cancer immunotherapy before delving into immune-related response criteria, adverse reactions, and immune-targeted combinations. Finally, the use of biomarkers for predicting responsiveness is examined.

This course is intended for primary care and specialty physicians, pharmacists, psychologists, physician assistants, nurses, and nurse practitioners.

What You'll Learn

  • Recognize the relationship between human cancer and immune therapy interventions
  • Identify the cancer immunity cycle
  • Analyze treatment, drugs, and algorithms
  • Examine immunity in metastatic setting for adjuvant patients
  • Examine immune-related response criteria, adverse reactions, and immune-targeted combinations
  • Determine how biomarkers can be utilized to predict responsiveness

Want to purchase this course for a group?

You can purchase enrollment codes for this course to distribute to your team

Purchase for a Group

Instructors

Stephen Hodi, MD

Stephen Hodi, MD Professor of Medicine, Harvard Medical School; Director of the Melanoma Center and the Center for Immuno-Oncology at Dana-Farber/Brigham and Women’s Cancer Center

COURSE OUTLINE

Cancer Immunotherapy for Internists is organized as follows:

Precourse Information:
Accreditation and AMA Credit Designation
Disclosure Statement
How to Take This Course
Viewing Videos
Grading and Certificates

Cancer Immunotherapy for Internists
Cancer and Immune Therapy Interventions
Immune Therapy Agents
Response to Immune Therapy Agents
Key Questions for Cancer Immune Therapy

CME Certificate
CME Posttest
Course Evaluation

ACCREDITATION AND AMA CREDIT DESIGNATION STATEMENTS

ACCREDITATION STATEMENT

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT

The Harvard Medical School designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC APPROVAL STATEMENT

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Every 30 days HMS GCE will upload participant data (name, date of birth, ABIM ID#, MOC points earned) for any learners who have completed this activity directly to their transcript at the ABIM via the ACCME's Program and Activity Reporting System (PARS). Since MOC points earned will be uploaded to your ABIM transcript these points will not appear on your CME certificate. If you do not see your points on your ABIM transcript after 30 days of completing the activity please contact Jillian West at HMS GCE at jillian_west@hms.harvard.edu.

DISCLOSURE STATEMENT

Disclosure Policy

Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients:

Name: F. Stephen Hodi, MD
Role: Faculty/Speaker
Company: Bristol-Myers Squibb
Relationship: Consultant
Company: Genentech
Relationship: Non-Paid Consultant
Company: Merck
Relationship: Consultant
Company: Novartis
Relationship: Consultant
Company: Amgen
Relationship: Consultant
Company: Sanofi
Relationship: Consultant
Company: FMD Serono
Relationship: Consultant

Name: Louis Pasquale, MD
Role: CME Committee Member and Reviewer
Company: Bausch + Lomb
Relationship: Paid Consultant
Company: Novartis
Relationship: Non-paid consultant
Company: Allergan
Relationship: Speaker
Company: Merck
Relationship: Unrestricted Grant

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.

COURSE DIRECTOR

J. Kevin Tucker, M.D. is an associate physician at Brigham and Women’s Hospital and assistant professor of medicine at Harvard Medical School. He is also the chief of nephrology at Brigham and Women’s/Faulkner Hospital and faculty director for accreditation and MOC in the Department of Postgraduate Medical Education at Harvard Medical School. Dr. Tucker received his undergraduate education at Birmingham-Southern College and completed his medical education at Cornell University Medical College. He trained in internal medicine at Massachusetts General Hospital and in nephrology at the University of Alabama at Birmingham. His clinical interests include chronic kidney disease, hemodialysis, and peritoneal dialysis.

FREQUENTLY ASKED QUESTIONS

How long will this course take?

This course should take approximately 1 hour to complete. You do not need to complete it all at once. You may come back as often as you like.

How long will this course be available?

This self-paced course will close enrollments one year after its start date.

What web browser should I use?

The platform works best with current versions of Chrome, Firefox, or Safari, or with Internet Explorer version 11 and above. See our list of supported browsers for the most up-to-date information.

What if I want to learn more about this topic?

HMS Continuing Education holds live topic-focused conferences throughout the year. Please see our course catalog for upcoming events.

Enroll